0.03 | 4.11%
| Price and Volume | |
|---|---|
| Recent Price | 0.76 |
| 52 Week High | 1.92 |
| 52 Week Low | 0.64 |
| Avg. Daily Vol. (Mil) | 0.08 |
| Beta (3 year) | 1.75 |
| Share Related Items | |
| Mkt Cap (Mil) | 21.93 |
| Shares Out (Mil) | 28.86 |
| Float (Mil) | 25.48 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.60 |
| Current Ratio | 1.90 |
| LT Debt/ Equity | 14.05 |
| Total Debt / Equity | 19.84 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.81 |
| Price/Book | 134.54 |
| Price/Cash Flow | -3.20 |
| Per Share Data | |
| Earnings | -0.26 |
| Sales | 0.42 |
| Book Value | 0.01 |
| Cash Flow | -0.24 |
| Business Summary | |
|---|---|
| Oculus Innovative Sciences, Inc. develops, manufactures and markets a family of tissue care products that cure infections and, through a separate mechanism of action, enhance healing while reducing the need for antibiotics. | |
| General Information | |
| 1129 North McDowell Blvd.
Petaluma, CA 94954 |
|
| www.oculusis.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 31 | |
| CEO: Mr. Hojabr Alimi | |
| Short Interest | |
| Current Month (Mil) | 0.29 |
| Previous Month (Mil) | 0.31 |
| Short Interest Ratio (Days) | 3.40 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -80.80 |
| Return on Investments | -295.00 |
| Profitability | |
| Gross Margin | 73.30 |
| EBIT Margin | -53.30 |
| Profit Margin | -59.90 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,580.69 | 1,332.42 | 2,870.99 | 16.75 |
Oil *
104.83
|
|
UP
125.86 |
UP
14.60 |
UP
33.46 |
DOWN
0.56 |
10 Yr
1.68%
SPDR Gold
151.02
|
|
+1.01%
|
+1.11%
|
+1.18%
|
-3.24%
|
Data delayed 20 minutes |
Connect with TheStreet